These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6438562)

  • 21. Production and characterization of monoclonal antibodies against Taylorella equigenitalis.
    Gradinaru DA; Helmer JM; Klein F
    Vet Res; 1997; 28(1):65-76. PubMed ID: 9172842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigens of selected Acanthamoeba species detected with monoclonal antibodies.
    Turner ML; Cockerell EJ; Brereton HM; Badenoch PR; Tea M; Coster DJ; Williams KA
    Int J Parasitol; 2005 Aug; 35(9):981-90. PubMed ID: 15964573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibodies against Schistosoma mekongi surface tegumental antigens.
    Viyanant V; Gajanadana O; Upatham ES; Sobhon P; Kruatrachue M; Ahmed S; Ardseungnoen P
    Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):484-8. PubMed ID: 7512753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antigen differences of genetic variants Abent+ and Abent- poliovirus vaccine strain of III type].
    Shyrobokov VP; Kostenko IH; Nikolaienko IV
    Mikrobiol Z; 2003; 65(4):29-36. PubMed ID: 14618784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease.
    Mattion N; König G; Seki C; Smitsaart E; Maradei E; Robiolo B; Duffy S; León E; Piccone M; Sadir A; Bottini R; Cosentino B; Falczuk A; Maresca R; Periolo O; Bellinzoni R; Espinoza A; Torre JL; Palma EL
    Vaccine; 2004 Oct; 22(31-32):4149-62. PubMed ID: 15474705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and characterization of monoclonal antibodies against excretory-secretory antigens of Fasciola gigantica.
    Viyanant V; Upatham ES; Sobhon P; Krailas D; Ardseungnoen P; Anatawara S
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 1():128-33. PubMed ID: 9656363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of biologic agents on infectious diseases.
    Saketkoo LA; Espinoza LR
    Infect Dis Clin North Am; 2006 Dec; 20(4):931-61, viii. PubMed ID: 17118297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies.
    Halstead SB; Venkateshan CN; Gentry MK; Larsen LK
    J Immunol; 1984 Mar; 132(3):1529-32. PubMed ID: 6607288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures.
    Schoppel K; Hassfurther E; Britt W; Ohlin M; Borrebaeck CA; Mach M
    Virology; 1996 Feb; 216(1):133-45. PubMed ID: 8614980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences between original strains and their mouse-adapted variants of human (H1) and avian (H2) influenza A viruses in the reaction with cross-neutralizing monoclonal antibody recognizing conformational epitope.
    Lipatov AS; Gitelman AK; Smirnov YuA
    Acta Virol; 1996 Sep; 40(4):227-30. PubMed ID: 9014015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies for the treatment of bacterial infections: current experience and future prospects.
    Bebbington C; Yarranton G
    Curr Opin Biotechnol; 2008 Dec; 19(6):613-9. PubMed ID: 19000762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmodium falciparum: production of human antibodies specific for the MSP-3 protein in the Hu-SPL-SCID mouse.
    Bouharoun-Tayoun H; Noun G; Druilhe P; Nakhlé C; Haddad N; Chamat S
    Exp Parasitol; 2004; 108(1-2):47-52. PubMed ID: 15491548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of Bartonella genus-specific monoclonal antibodies.
    Liang Z; La Scola B; Lepidi H; Raoult D
    Clin Diagn Lab Immunol; 2001 Jul; 8(4):847-9. PubMed ID: 11427441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HA2-specific monoclonal antibodies as tools for differential recognition of influenza A virus antigenic subtypes.
    Varecková E; Mucha V; Kostolanský F; Gubareva LV; Klimov A
    Virus Res; 2008 Mar; 132(1-2):181-6. PubMed ID: 18037184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibodies against antigenic epitopes common between Setaria cervi and Brugia malayi.
    Kaushal NA; Kaushal DC; Ghosh S; Talwar GP
    Indian J Exp Biol; 1994 Jun; 32(6):371-5. PubMed ID: 7525468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of monoclonal antibodies with ferret sera for the characterization of influenza A (H3N2) virus strains in a computer system.
    Osterhaus AD; Weijers TF; Bijlsma K; de Ronde-Verloop FM; van Asten JA; de Jong JC
    Dev Biol Stand; 1984; 57():245-50. PubMed ID: 6526140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Monoclonal antibodies in infectious diseases: new partners in the therapeutic arsenal].
    Desoubeaux G; Pelegrin M
    Med Sci (Paris); 2019 Dec; 35(12):1008-1013. PubMed ID: 31903909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chaos, persistence, and evolution of strain structure in antigenically diverse infectious agents.
    Gupta S; Ferguson N; Anderson R
    Science; 1998 May; 280(5365):912-5. PubMed ID: 9572737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The use of monoclonal antibodies in veterinary research].
    van Zaane D
    Tijdschr Diergeneeskd; 1985 Oct; 110(20):818-22. PubMed ID: 4071520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies in clinical medicine.
    Dick HM
    Br Med J (Clin Res Ed); 1985 Sep; 291(6498):762-4. PubMed ID: 3929932
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.